BACKGROUND: Remodeling of ion channel expression is well established in heart failure (HF). We determined the extent to which I(to) is reduced in tachypacing-induced HF and assessed the ability of an I(to) activator (NS5806) to recover this current. METHOD AND RESULTS: Whole-cell patch clamp was used to record I(to) in epicardial (Epi) ventricular myocytes. Epi- and endocardial action potentials were recorded from left ventricular wedge preparations. Right ventricular tachypacing-induced heart failure reduced I(to) density in Epi myocytes (Control=22.1±1.9pA/pF vs 16.1±1.4 after 2weeks and 10.7±1.4pA/pF after 5 weeks, +50mV). Current decay as well as recovery of I(to) from inactivation progressively slowed with the development of heart failure. Reduction of I(to) density was paralleled by a reduction in phase 1 magnitude, epicardial action potential notch and J wave amplitude recorded from coronary-perfused left ventricular wedge preparations. NS5806 increased I(to) (at +50mV) from 16.1±1.4 to 23.9±2.1pA/pF (p<0.05) at 2weeks and from 10.7±1.4 to 14.4±1.9pA/pF (p<0.05) in 5 weeks tachypaced dogs. NS5806 increased both fast and slow phases of I(to) recovery in 2 and 5-week HF cells and restored the action potential notch and J wave in wedge preparations from HF dogs. CONCLUSIONS: The I(to) agonist NS5806 increases the rate of recovery and density of I(to), thus reversing the HF-induced reduction in these parameters. In wedge preparations from HF dogs, NS5806 restored the spike-and-dome morphology of the Epi action potential providing proof of principal that some aspects of electrical remodelling during HF can be pharmacologically reversed.
BACKGROUND: Remodeling of ion channel expression is well established in heart failure (HF). We determined the extent to which I(to) is reduced in tachypacing-induced HF and assessed the ability of an I(to) activator (NS5806) to recover this current. METHOD AND RESULTS: Whole-cell patch clamp was used to record I(to) in epicardial (Epi) ventricular myocytes. Epi- and endocardial action potentials were recorded from left ventricular wedge preparations. Right ventricular tachypacing-induced heart failure reduced I(to) density in Epi myocytes (Control=22.1±1.9pA/pF vs 16.1±1.4 after 2weeks and 10.7±1.4pA/pF after 5 weeks, +50mV). Current decay as well as recovery of I(to) from inactivation progressively slowed with the development of heart failure. Reduction of I(to) density was paralleled by a reduction in phase 1 magnitude, epicardial action potential notch and J wave amplitude recorded from coronary-perfused left ventricular wedge preparations. NS5806 increased I(to) (at +50mV) from 16.1±1.4 to 23.9±2.1pA/pF (p<0.05) at 2weeks and from 10.7±1.4 to 14.4±1.9pA/pF (p<0.05) in 5 weeks tachypaced dogs. NS5806 increased both fast and slow phases of I(to) recovery in 2 and 5-week HF cells and restored the action potential notch and J wave in wedge preparations from HF dogs. CONCLUSIONS: The I(to) agonist NS5806 increases the rate of recovery and density of I(to), thus reversing the HF-induced reduction in these parameters. In wedge preparations from HF dogs, NS5806 restored the spike-and-dome morphology of the Epi action potential providing proof of principal that some aspects of electrical remodelling during HF can be pharmacologically reversed.
Authors: Jonathan M Cordeiro; Lindsey Greene; Cory Heilmann; Daniel Antzelevitch; Charles Antzelevitch Journal: Am J Physiol Heart Circ Physiol Date: 2003-12-11 Impact factor: 4.733
Authors: Rajan Sah; Rafael J Ramirez; Gavin Y Oudit; Dominica Gidrewicz; Maria G Trivieri; Carsten Zobel; Peter H Backx Journal: J Physiol Date: 2003-01-01 Impact factor: 5.182
Authors: Lisa Murphy; Danielle Renodin; Charles Antzelevitch; José M Di Diego; Jonathan M Cordeiro Journal: Am J Physiol Heart Circ Physiol Date: 2011-06-17 Impact factor: 4.733
Authors: Isabelle Deschênes; Deborah DiSilvestre; George J Juang; Richard C Wu; W Frank An; Gordon F Tomaselli Journal: Circulation Date: 2002-07-23 Impact factor: 29.690
Authors: Jonathan M Cordeiro; Tanya Zeina; Robert Goodrow; Aaron D Kaplan; Lini M Thomas; Vladislav V Nesterenko; Jacqueline A Treat; Leo Hawel; Craig Byus; Glenna C Bett; Randall L Rasmusson; Brian K Panama Journal: J Mol Cell Cardiol Date: 2015-04-15 Impact factor: 5.000
Authors: Alexander Burashnikov; José M Di Diego; Hector Barajas-Martínez; Dan Hu; Andrew C Zygmunt; Jonathan M Cordeiro; N Sydney Moise; Bruce G Kornreich; Luiz Belardinelli; Charles Antzelevitch Journal: Circ Heart Fail Date: 2014-05-29 Impact factor: 8.790
Authors: Kirstine Calloe; Robert Goodrow; Søren-Peter Olesen; Charles Antzelevitch; Jonathan M Cordeiro Journal: Am J Physiol Heart Circ Physiol Date: 2013-05-03 Impact factor: 4.733